{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:15:55Z","timestamp":1781543755565,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jep.2022.115897","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T13:00:31Z","timestamp":1667394031000},"page":"115897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"PA","title":["Total glucosides of paeony alleviates scleroderma by inhibiting type I interferon responses"],"prefix":"10.1016","volume":"302","author":[{"given":"Shuo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhao","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jep.2022.115897_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/art.27224","article-title":"Systemic sclerosis and lupus: points in an interferon-mediated continuum","volume":"62","author":"Assassi","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.jep.2022.115897_bib2","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/art.39289","article-title":"Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis","volume":"67","author":"Assassi","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.jep.2022.115897_bib3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.20998","article-title":"Activation of the type I interferon system in primary Sj\u00f6gren's syndrome: a possible etiopathogenic mechanism","volume":"52","author":"B\u00e5ve","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jep.2022.115897_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R","article-title":"Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Black","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jep.2022.115897_bib5","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1002\/cpim.88","article-title":"Experimental mouse model of bleomycin-induced skin fibrosis","volume":"126","author":"B\u0142yszczuk","year":"2019","journal-title":"Curr. Protoc. Im."},{"issue":"8","key":"10.1016\/j.jep.2022.115897_bib6","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jep.2022.115897_bib7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cei.13238","article-title":"The immunopathogenesis of fibrosis in systemic sclerosis","volume":"195","author":"Brown","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jep.2022.115897_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153495","article-title":"Si-Ni-San ameliorates chronic colitis by modulating type I interferons-mediated inflammation","volume":"84","author":"Cai","year":"2021","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.jep.2022.115897_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/annrheumdis-2011-200275","article-title":"Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis","volume":"71","author":"Carmona","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.jep.2022.115897_bib10","first-page":"669","article-title":"[Effect of total glucosides of paeony on nuclear factor-kappaB activation in rat peritoneal macrophages]","volume":"33","author":"Chen","year":"2008","journal-title":"Zhongguo Zhongyao Zazhi"},{"issue":"1","key":"10.1016\/j.jep.2022.115897_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s40425-019-0757-z","article-title":"IL-17 inhibits CXCL9\/10-mediated recruitment of CD8(+) cytotoxic T cells and regulatory T cells to colorectal tumors","volume":"7","author":"Chen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jep.2022.115897_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.668507","article-title":"Interleukin-6, CXCL10 and infiltrating macrophages in COVID-19-related cytokine storm: not one for all but all for one","volume":"12","author":"Coperchini","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jep.2022.115897_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jep.2022.115897_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2018.04.032","article-title":"Anti-inflammatory and immune response regulation of Si-Ni-San in 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin dysfunction","volume":"222","author":"Fan","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.jep.2022.115897_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/ard.2010.132464","article-title":"dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts","volume":"70","author":"Farina","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.jep.2022.115897_bib16","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1038\/jid.2010.200","article-title":"Poly(I:C) drives type I IFN- and TGF\u03b2-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis","volume":"130","author":"Farina","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.jep.2022.115897_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.30193","article-title":"Association of a functional IRF7 variant with systemic lupus erythematosus","volume":"63","author":"Fu","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jep.2022.115897_bib18","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.12688\/f1000research.26728.1","article-title":"Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases","volume":"9","author":"Groover","year":"2020","journal-title":"F1000Res"},{"issue":"10","key":"10.1016\/j.jep.2022.115897_bib19","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1038\/jid.2015.188","article-title":"Suppression of T Cell activation and collagen accumulation by an anti-IFNAR1 mAb, anifrolumab, in adult patients with systemic sclerosis","volume":"135","author":"Guo","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"7713","key":"10.1016\/j.jep.2022.115897_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting STING with covalent small-molecule inhibitors","volume":"559","author":"Haag","year":"2018","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jep.2022.115897_bib21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.12968\/hmed.2019.80.9.530","article-title":"Systemic sclerosis","volume":"80","author":"Hughes","year":"2019","journal-title":"Br. J. Hosp. Med."},{"issue":"1","key":"10.1016\/j.jep.2022.115897_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.jep.2022.115897_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12016-020-08798-2","article-title":"Type I interferons in the pathogenesis and treatment of autoimmune diseases","volume":"59","author":"Jiang","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jep.2022.115897_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fimmu.2015.00609","article-title":"Subsets and its therapeutic implications in autoimmune and cancer DisThe role of chemokines in shaping the balance between CD4(+) T cell eases","volume":"6","author":"Karin","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jep.2022.115897_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","article-title":"RIG-I in RNA virus recognition","volume":"479\u2013480","author":"Kell","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.jep.2022.115897_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev-med-050715-104506","article-title":"The type I interferonopathies","volume":"68","author":"Lee-Kirsch","year":"2017","journal-title":"Annu. Rev. Med."},{"issue":"5","key":"10.1016\/j.jep.2022.115897_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2008.12.002","article-title":"CXCL10 and autoimmune diseases","volume":"8","author":"Lee","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jep.2022.115897_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.phrs.2019.04.025","article-title":"Natural products in licorice for the therapy of liver diseases: progress and future opportunities","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jep.2022.115897_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cytogfr.2015.12.002","article-title":"New insights into CD4(+) T cell abnormalities in systemic sclerosis","volume":"28","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.jep.2022.115897_bib30","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1172\/JCI131700","article-title":"Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis","volume":"130","author":"Maehara","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.jep.2022.115897_bib31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/exd.12727","article-title":"Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma","volume":"24","author":"Manetti","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.jep.2022.115897_bib32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/BOR.0000000000000331","article-title":"Animal models of scleroderma: recent progress","volume":"28","author":"Marangoni","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jep.2022.115897_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","article-title":"Gender differences in autoimmune disease","volume":"35","author":"Ngo","year":"2014","journal-title":"Front. Neuroendocrinol."},{"issue":"11","key":"10.1016\/j.jep.2022.115897_bib34","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10067-008-0972-3","article-title":"The development of systemic sclerosis in a female patient with multiple sclerosis following beta interferon treatment","volume":"27","author":"Powell","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jep.2022.115897_bib35","article-title":"An acute bleomycin inflammatory and fibrotic mouse model of morphea is dependent upon CXCL9 and CXCR3","author":"Richmond","year":"2019","journal-title":"medRxiv"},{"key":"10.1016\/j.jep.2022.115897_bib36","first-page":"2029","article-title":"Treatment of 116 cases of ulcerative colitis with liver-depression type with Modified Sini Powder","volume":"35","author":"Ru","year":"2015","journal-title":"Henan Province Tradition"},{"issue":"49","key":"10.1016\/j.jep.2022.115897_bib37","doi-asserted-by":"crossref","first-page":"15136","DOI":"10.1073\/pnas.1520997112","article-title":"Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis","volume":"112","author":"Saigusa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.jep.2022.115897_bib38","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1074\/jbc.R116.774562","article-title":"The molecular basis for differential type I interferon signaling","volume":"292","author":"Schreiber","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2022.115897_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2018.12.018","article-title":"Type I interferon dysregulation in systemic sclerosis","volume":"132","author":"Skaug","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.jep.2022.115897_bib40","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3389\/fimmu.2019.01525","article-title":"The role of epigenetics in autoimmune\/inflammatory disease","volume":"10","author":"Surace","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.jep.2022.115897_bib41","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/ard.2006.063412","article-title":"Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients","volume":"66","author":"van der Pouw Kraan","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.jep.2022.115897_bib42","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jep.2022.115897_bib43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jep.2010.10.022","article-title":"The expression change of \u03b2-arrestins in fibroblast-like synoviocytes from rats with collagen-induced arthritis and the effect of total glucosides of paeony","volume":"133","author":"Wang","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2022.115897_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13020-020-00371-5","article-title":"Flavonoids from aurantii fructus immaturus and aurantii fructus: promising phytomedicines for the treatment of liver diseases","volume":"15","author":"Wu","year":"2020","journal-title":"Chin. Med."},{"issue":"11","key":"10.1016\/j.jep.2022.115897_bib45","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2019-215208","article-title":"Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis","volume":"78","author":"Wu","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.jep.2022.115897_bib46","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jep.2022.115897_bib47","series-title":"Effects of Total Glucosides of Paeony, N-Acetylcysteine and Thalidomide on Pulmonary Interstitial Fibrosis Induced by Bleomycin in Mice with Scleroderma","author":"Xiao","year":"2007"},{"issue":"1","key":"10.1016\/j.jep.2022.115897_bib48","first-page":"68","article-title":"[Effects of interferon-alpha combined with saikosaponin on serum T lymphocyte subgroups and hepatic cytokines in mice with immune hepatic injury]","volume":"32","author":"Xue","year":"2012","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.jep.2022.115897_bib49","first-page":"150","article-title":"A study on the therapeutic effect of total glucosides of paeony on the mice with scleroderma and its mechanisms","volume":"12","author":"Zhang","year":"2017","journal-title":"Journal of Chengdu Medical College"},{"key":"10.1016\/j.jep.2022.115897_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107452","article-title":"Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony","volume":"207","author":"Zhang","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jep.2022.115897_bib51","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3389\/fphar.2019.01518","article-title":"Si-Ni-San prevents reserpine-induced depression by inhibiting inflammation and regulating CYP450 enzymatic activity","volume":"10","author":"Zong","year":"2019","journal-title":"Front. Pharmacol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874122009369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874122009369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:35:05Z","timestamp":1759944905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874122009369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":51,"alternative-id":["S0378874122009369"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2022.115897","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total glucosides of paeony alleviates scleroderma by inhibiting type I interferon responses","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2022.115897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115897"}}